Literature DB >> 17113231

Association of APOE with Parkinson disease age-at-onset in women.

Daniel D Buchanan1, Peter A Silburn, Jonathan A Prince, George D Mellick.   

Abstract

APOE polymorphism has received extensive attention as a risk factor for Parkinson's disease (PD), but findings have been equivocal. Analysis of APOE variants in an Australian PD case-control sample revealed a robust association between genotype and age-at-onset (AAO) of PD in women (P=0.0008). These data not only further implicate APOE in PD, but also provide a stark example of the effects that gender may play in complex disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17113231     DOI: 10.1016/j.neulet.2006.07.080

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  A large study reveals no association between APOE and Parkinson's disease.

Authors:  Monica Federoff; Belen Jimenez-Rolando; Michael A Nalls; Andrew B Singleton
Journal:  Neurobiol Dis       Date:  2012-02-12       Impact factor: 5.996

Review 2.  HDL and cognition in neurodegenerative disorders.

Authors:  David A Hottman; Dustin Chernick; Shaowu Cheng; Zhe Wang; Ling Li
Journal:  Neurobiol Dis       Date:  2014-08-13       Impact factor: 5.996

3.  Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease.

Authors:  Caroline H Williams-Gray; An Goris; Misuzu Saiki; Thomas Foltynie; D Alastair S Compston; Stephen J Sawcer; Roger A Barker
Journal:  J Neurol       Date:  2009-03-18       Impact factor: 4.849

4.  Function and comorbidities of apolipoprotein e in Alzheimer's disease.

Authors:  Valérie Leduc; Dorothée Domenger; Louis De Beaumont; Daphnée Lalonde; Stéphanie Bélanger-Jasmin; Judes Poirier
Journal:  Int J Alzheimers Dis       Date:  2011-04-05

5.  Impact of genetic variants of apolipoprotein E on lipid profile in patients with Parkinson's disease.

Authors:  Michele L Gregório; Marcela A S Pinhel; Caroline L Sado; Gabriela S Longo; Fábio N Oliveira; Gisele S Amorim; Marcelo A Nakazone; Greiciane M Florim; Camila M Mazeti; Denise P Martins; Waldir A Tognola; Antonio C Brandão; Sidney Pinheiro Júnior; Moacir F de Godoy; Dorotéia R S Souza
Journal:  Biomed Res Int       Date:  2013-09-24       Impact factor: 3.411

Review 6.  Emerging preclinical pharmacological targets for Parkinson's disease.

Authors:  Sandeep Vasant More; Dong-Kug Choi
Journal:  Oncotarget       Date:  2016-05-17

7.  The genetic association between apolipoprotein E gene polymorphism and Parkinson disease: A meta-Analysis of 47 studies.

Authors:  Jianming Li; Jia Luo; Li Liu; Hui Fu; Liang Tang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

Review 8.  Role of apolipoprotein E in neurodegenerative diseases.

Authors:  Vo Van Giau; Eva Bagyinszky; Seong Soo A An; Sang Yun Kim
Journal:  Neuropsychiatr Dis Treat       Date:  2015-07-16       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.